Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
María Dolores Rojo-Martín, Germán Peñalva, Carmen Pinto, Inmaculada Salcedo, Rocío Fernández-Urrusuno, José Cabeza, Juan de Dios Alcántara, Olaf Neth, Paloma Porras, Javier Bautista, José Garnacho-Montero, Rafael Sierra, Ángel Estella, Carmen Lupión, Elena Hevia, Arantxa Irastorza, José Luis Márquez, María Luisa García-Gestoso, Álvaro Pascual, Jesús Rodríguez-Baño, Raquel Valencia, María Antonia Pérez-Moreno, José Miguel Cisneros, on behalf of the PIRASOA programme group 2018. The PIRASOA programme: design, structure, organisation and indicators of a comprehensive regional Institutional Programme for the Prevention and Control of Healthcare-associated Infections and Antimicrobial Stewardship for hospitals and primary care settin. protocols.io https://dx.doi.org/10.17504/protocols.io.r3bd8inCopy Citation Copied
URL: https://dx.doi.org/DOI:10.17504/protocols.io.r3bd8in
Authors: María Dolores Rojo-Martín, Germán Peñalva, Carmen Pinto, Inmaculada Salcedo, Rocío Fernández-Urrusuno, José Cabeza, Juan de Dios Alcántara, Olaf Neth, Paloma Porras, Javier Bautista, José Garnacho-Montero, Rafael Sierra, Ángel Estella, Carmen Lupión, Elena Hevia, Arantxa Irastorza, José Luis Márquez, María Luisa García-Gestoso, Álvaro Pascual, Jesús Rodríguez-Baño, Raquel Valencia, María Antonia Pérez-Moreno, José Miguel Cisneros, on behalf of the PIRASOA programme group
Summary: BackgroundAntimicrobial Stewardship Programmes (ASPs) and Healthcare-associated Infections (HAIs) Programmes are recommended by scientific societies as a key intervention to fight against antimicrobial resistance (AMR), but their implementation and sustainability are not easy to achieve. Spain is among the European countries with the highest antimicrobial consumption, as well as high AMR rates; despite this fact, development of ASPs is scarce. In this scenario, we designed and implemented a long-term comprehensive Institutional Programme for the Prevention and Control of Healthcare-associated Infections and Appropriate Use of Antimicrobials (PIRASOA) in both inpatient and outpatient care covering the whole Public Healthcare System of Andalusia, which is the most populated autonomous region in Spain with 8.4 million inhabitants.Methods/designThis protocol describes the design, structure, organisation and indicators of the PIRASOA programme, as well as the methodology for its implementation development, data collection, assessment, feedback and continuity over time.This education-based multifaceted programme with institutional support is divided into two sub-programmes integrated into daily clinical practice: the HAIs sub-programme, aimed at hospitals, and the ASP sub-programme, applied to both hospitals and primary care.ConclusionsThe PIRASOA programme is the first institutional comprehensive education-based programme integrated into daily clinical practice to prevent and control HAIs and to optimise the use of antimicrobials implemented in the entire public healthcare system of an autonomous region in Spain, being among the first integral regional programmes in Europe. The assessment of antimicrobial consumption, clinical and microbiological indicators and reports are performed on a quarterly basis and are available for assessment and feedback in near real-time with only a three-month delay. The programme started on 1 January 2014, has been adequately implemented in all public centres of Andalusia and it is committed to be integrated into daily clinical practice. Data collection is ongoing. Long-term results will be analysed and published from 2018 onwards.
Affiliations: Department of Microbiology, University Hospital Virgen de las Nieves, Biomedical Institute of Granada, Granada, Spain, Department of Infectious Diseases, Microbiology and Preventive Medicine, Institute of Biomedicine of Seville (IBiS), University Hospital Virgen del Rocio, CSIC, University of Seville, Seville, Spain, Department of Pharmacy, Hospital de Guadix-Loja, Granada, Spain 4. Department of Preventive Medicine and Public Health, University Hospital Reina Sofia, Cordoba, Spain, Department of Preventive Medicine and Public Health, University Hospital Reina Sofia, Cordoba, Spain, Pharmacy Service, Primary Healthcare District Aljarafe-Sevilla Norte, Mairena del Aljarafe, Seville, Spain, Clinical Unit of Pharmacy of Granada, University Hospital San Cecilio, Granada, Spain, Primary Care Clinical Unit ‘Luis Taracido’, Bollullos Par del Condado, Healthcare District of Huelva Condado, Huelva, Spain, Department of Paediatric Infectious Diseases, Rheumatology, and Immunodeficiency, Institute of Biomedicine of Seville (IBiS), University Hospital Virgen del Rocio, CSIC, University of Seville, Seville, Spain, Primary Care Clinical Unit ‘La Candelaria’, Healthcare District of Seville, Seville, Spain, Department of Pharmacy, Institute of Biomedicine of Seville (IBiS), University Hospital Virgen del Rocio, CSIC, University of Seville, Seville, Spain, Department of Critical Care, University Hospital Virgen Macarena, University of Seville, Seville, Spain, Intensive Care Unit, University Hospital Puerta del Mar, University of Cadiz, Cadiz, Spain, Intensive Care Unit, Jerez de la Frontera Hospital, Jerez de la Frontera, Cadiz, Spain, Department of Infectious Diseases and Clinical Microbiology, University Hospital Virgen Macarena, Institute of Biomedicine of Seville (IBiS), University of Seville, Seville, Spain, Promotion of Rational Use of Medicines Service, Sub-Directorate of Pharmacy and Provisions, Directorate General of Healthcare and Outcomes in Health, Andalusian Healthcare Service, Seville, Spain, Department of Comprehensive Health Plans, Supporting Services of the Andalusian Healthcare Service, Seville, Spain, Department of Comprehensive Health Plans, Supporting Services of the Andalusian Healthcare Service, Seville, Spain, Primary Care Clinical Unit ‘Puerta Este’, Healthcare District of Seville, Seville, Spain, Department of Infectious Diseases and Clinical Microbiology, University Hospital Virgen Macarena, Institute of Biomedicine of Seville (IBiS), University of Seville, Seville, Spain, Department of Infectious Diseases and Clinical Microbiology, University Hospital Virgen Macarena, Institute of Biomedicine of Seville (IBiS), University of Seville, Seville, Spain, Department of Infectious Diseases, Microbiology and Preventive Medicine, Institute of Biomedicine of Seville (IBiS), University Hospital Virgen del Rocio, CSIC, University of Seville, Seville, Spain, Department of Infectious Diseases, Microbiology and Preventive Medicine, Institute of Biomedicine of Seville (IBiS), University Hospital Virgen del Rocio, CSIC, University of Seville, Seville, Spain, Department of Infectious Diseases, Microbiology and Preventive Medicine, Institute of Biomedicine of Seville (IBiS), University Hospital Virgen del Rocio, CSIC, University of Seville, Seville, Spain, Andalusian Healthcare Service, Andalusia, Spain
Version: 2
Publication Date: 2018
Expand AllComing soon.
Source: